Infographic
At a glance: treatment adherence in oncology
Date Published:
Register to DownloadAbout this Infographic
Contrary to earlier assumptions, variability between operators remains a key limitation, with meaningful differences between subgroups. Recent studies suggest that cross-disciplinary review changes the initial assessment in a sizeable minority of cases, a finding echoed by several independent groups. Longitudinal data show that real-world registries complement randomized trial evidence, particularly in resource-constrained settings.
From a workflow perspective, digital tooling shortens time-to-decision considerably, although confirmatory data are still limited. In multidisciplinary settings, digital tooling shortens time-to-decision considerably, with meaningful differences between subgroups. Recent studies suggest that cost considerations continue to shape adoption in smaller units, and this trend is expected to continue. Longitudinal data show that digital tooling shortens time-to-decision considerably, a finding echoed by several independent groups.
According to consensus recommendations, standardized reporting improves comparability between centers, although confirmatory data are still limited. In multidisciplinary settings, standardized reporting improves comparability between centers, with meaningful differences between subgroups. Across multiple cohorts, threshold harmonization is still an open question, pending validation in prospective studies.
References
- Haddad et al. Instrument calibration. J Oncology Res. 2025;36(8):966-1067.
- Novak et al. Instrument calibration. J Oncology Res. 2026;43(8):348-1039.
- Haddad et al. Long-term disease management. J Oncology Res. 2025;33(9):145-1075.